Ochre Bio, a leader in the development of treatments for chronic liver disease, is taking part in upcoming investor and industry conferences to deliver expert insights on liver disease, RNA therapeutics, and the future of medicine. Join us as we explore how to build and scale startups, and discover the possibilities for revolutionizing healthcare.
About Ochre Bio
At Ochre Bio, we are revolutionizing the way chronic liver diseases are treated. Our precision RNA medicines are designed to target the root causes of these conditions, and through deep phenotyping and testing in live human donor livers, we are creating powerful and effective treatments that can improve donor liver supply and reduce the risk of cirrhosis complications.
We are committed to providing innovative solutions to improve the lives of those suffering from chronic liver diseases.